Kimberly Kraig Thompson - 12 May 2022 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Role
CEO & CFO, Director, 10%+ Owner
Signature
/s/ Kim Thompson
Issuer symbol
KBLB
Transactions as of
12 May 2022
Net transactions value
$0
Form type
4
Filing time
16 May 2022, 16:30:27 UTC
Previous filing
12 May 2022
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KBLB Common Stock Sale -20,000 -0.01% 202,947,372 12 May 2022 Direct F1, F3
transaction KBLB Common Stock Sale -22,500 -0.01% 202,924,872 13 May 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on May 12, 2022 at $0.0725.
F2 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on May 13, 2022 at $0.0716.
F3 Includes 2 shares of common stock that may be issued upon conversion of the Series A Preferred Stock that are owned by Mr. Thompson, and the remainder consists of common stock Mr. Thompson owns.